Medical management of pulmonary disease caused by Mycobacterium avium complex

The current medical therapy for Mycobacterium avium complex is controversial. American Thoracic Society recommendations advocate empiric therapy with drug susceptibility testing only for clarithromycin. At National Jewish, where we mainly see cases complicated by treatment failure and drug intoleran...

Celý popis

Podrobná bibliografia

Vydané v:	Clinics in chest medicine Ročník 23; číslo 3; s. 633
Hlavný autor:	Iseman, Michael D
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.09.2002
Predmet:	Anti-Bacterial Agents Antitubercular Agents - therapeutic use Clinical Trials as Topic Drug Therapy, Combination - therapeutic use Humans Microbial Sensitivity Tests Mycobacterium avium Complex - pathogenicity Mycobacterium avium-intracellulare Infection - drug therapy Mycobacterium avium-intracellulare Infection - microbiology Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - microbiology
ISSN:	0272-5231
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!